California is the place to be for surrogacy…again

While we do not always prefer to toot our own horns here in California, the following piece regarding the state of surrogacy in Louisiana again proves that California IS the place to be. Let’s be honest though, for those of us working in the fertility industry, the decision by Louisiana Governor, Bobby Jindal, to veto legal surrogacy in Louisiana actually dodges the hopes of any prospective intended parents, surrogates, and IVF physicians alike located in Louisiana. But politics are politics, as the Governor stated in his official letter following the veto: “Despite the good intentions and hard efforts of the author, this legislation still.
Read More

Huffington post article – Why is egg donation not regulated?

In a “fluff” piece by the Huffington Post, we get the sense that the coverage should actually be called, “Why are egg donation agencies not regulated? “ After reviewing the piece and listening to the stories, it appears that the coverage should focus more on the physicians who are medically treating the egg donors and not the agencies.  Who controls the cycle?  Who monitors the egg donors regarding hyper-stimulation? Egg donor agencies are doing exactly what they have always been doing – matching egg donors with parents and are covered by each state’s Business and Professions code.  Should egg donor agencies do.
Read More

Gay fathers in texas denied parenthood

A recent article in the Huffington Post describing the perils of a gay couple underscores the importance of good legal advice prior to embarking on new family creation.  This situation would not have happened were these intended parents working with a surrogate in California. They were denied being the parents of their own biological children because Texas has a ban on gay marriage.  Furthermore, they are not able to co-adopt the other’s biological child.  These new fathers remain in a legal quagmire. Omega Family Global’s Chief Counsel, Frederick Gaston, had this to say “This is indeed a sad outcome. Had this.
Read More

Three parent IVF: should we be scared?

The media have termed the use of cytoplasmic material from another party in In Vitro Fertilization (IVF), Three Parent IVF. The rationale for using cytoplasmic material from a third party (egg) is to obtain the mitochondria. Some Intended Parents cannot have children or want to have children due to inherited mitochondrial diseases. This technique brings hope to those Intended Parents with mitochondrial diseases. The topic is not new, it is only getting new media and public attention. Some media reports on the topic make it sound scary, or ethically incorrect and akin to genetic engineering. The New York Times has.
Read More

No link between fertility drugs and breast, ovarian and uterine cancers

Many women undergoing fertility treatments have concern that these extra doses of hormones might set the stage for future health risks such as cancer.   Results of a 30-year study addressing this very topic were presented at the annual meeting of the the European Society of Human Reproduction and Embryology.  Study authors reported There is “little evidence” that the use of conventional fertility hormones used for ovarian stimulation in the treatment of infertility increases the long-term risk of breast and gynecological cancers, according to the results of a substantial 30-year follow-up study. Omega Family Global´s Dr. Kramer says the results are reassuring and.
Read More

Coming to america – for a surrogate and a baby

This past three-day long weekend the New York Times posted an interesting article  regarding couples coming to the US in order to create their family via surrogacy.  It touches on how far this industry has come over the last decade – with California notably being the best place in the country (and the world) to do surrogacy.   Omega Family Global knows this story well, as many of it´s clients are from outside the United States. Quote from Article: The restrictions in many countries have been a boost for American surrogacy. For overseas couples, the big draw is the knowledge that.
Read More

European human rights court orders france to recognise surrogate-mother children

Two French couples that had children via surrogates in the United States challenged the French government that refused to recognize the French citizenship of the children.    The couples took their case to The European Court of Human Rights and won victory (July 9, 2014). Omega Family Global´s Director of Client Relations, Allie Salinas, had this to say about the news “Omega Family Global has been very lucky in that the steps we have taken to help our French clients have resulted in the successful registration of their children.  However, we understand the struggles of the couples in the article as.
Read More

Calif. health insurers must cover fertility treatments for gay couples

This is a fascinating story  with a potentially huge impact for same sex couples in California entitled Calif. Health Insurers Must Cover Fertility Treatments for Gay Couples. Here is a link to the law itself. (AB460.pdf) The costs associated with fertility treatments has long been a barrier to folks desiring to start a family. This should help enable more people to start their families that were previously unable to do so due to financial reasons.
Read More

Obama urges congress to ban job bias against gays

Today President Obama called on Congress to ban job discrimination against gay Americans as he signed an executive order doing so for workers of federal contractors.  The President took the opportunity point out that Congress has debated such legislation for decades without agreeing to it, and he implored his supporters to raise the temperature on lawmakers even as they have achieved great momentum in the drive to legalize same-sex marriage through much of the nation.  The story can be viewed here (New York Times). According to Omega Family Global´s Chief Counsel, Frederick Gaston, this is a move in the right direction..
Read More

IVF possibly even safer with use of kisspeptin

Results of a recent study using Kisspeptin, instead of Human Chorionic Gonadotropin (hCG), have shown success in stimulating oocyte (egg) development in women undergoing fertility treatment.  The potential advantage of this new hormonal treatment is that a small number of women (1-2%) treated with hCG experience ovarian hyper stimulation syndrome which in rare cases can be fatal. The relatively small study was conducted by researchers from Imperial College London and Hammersmith Hospital, and was funded by the Medical Research Council, Welcome Trust and National Institute for Health Research. The study was published in The study was published in The Journal of.
Read More